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Abstract
There is substantial evidence for PGE2 affecting intestinal epithelial proliferation. PGE2 is also reported to be involved in the
regulation of growth and differentiation in adult stem cells, both effects mediated by binding to EP-receptors. We have used
the Lgr5 as a marker to scrutinize EP-receptor and COX expression in human intestinal epithelial cells with focus on the stem
cell area of the crypts. Normal tissue from ileum and colon, but also duodenal biopsies from patients with untreated celiac
disease, were investigated by immunohistochemistry and RT-PCR. The combination of fresh flash-frozen tissue and laser
microdissection made it possible to isolate RNA from the epithelial cell layer, only. In the small intestine, Lgr5 labels cells are
in the +4 position, while in the colon, Lgr5 positive cells are localized to the crypt bottoms. Epithelial crypt cells of normal
small intestine expressed neither EP-receptor mRNA nor COX1/2. However, crypt cells in tissue from patients with untreated
celiac disease expressed EP2/4 receptor and COX1 mRNA. In the colon, the situation was different. Epithelial crypt cells from
normal colon were found to express EP2/4 receptor and COX1/2 transcripts. Thus, there are distinct differences between
normal human small intestine and colon with regard to expression of EP2/4 receptors and COX1/2. In normal colon tissue,
PGE2-mediated signaling through EP-receptors 2/4 could be involved in regulation of growth and differentiation of the
epithelium, while the lack of EP-receptor expression in the small intestinal tissue exclude the possibility of a direct effect of
PGE2 on the crypt epithelial cells.
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Introduction
There is growing evidence that prostaglandins, and PGE2 in
particular, affect intestinal epithelial cell proliferation and
apoptosis [1]. The two cyclooxygenase (COX) isoforms, COX-1
and COX-2, both catalyze the conversion of arachidonic acid (AA)
into the intermediates PGG2 and PGH2, that subsequently acts as
substrate for specific prostaglandin (PG) synthases and the
formation of the different prostanoids [2]. COX-1 is suggested
to be constitutively expressed in most cells and tissues under
normal circumstances. COX-2 is usually absent or only weakly
expressed, but is induced in response to inflammatory mediators,
growth factors, oncogene activation and tumor promoters [3].
PGE2 is the most prominent prostaglandin and mediates its effects
by binding to E prostanoid receptors (EP receptors). Four different
EP receptors exist, EP1-4, which are all G-protein coupled
receptors (GPCRs).
Deficiency of endogenous prostaglandins due to inhibition of
the COX enzymes by nonsteroidal anti-inflammatory drugs
(NSAIDs) is important for ulcerogenic response in the intestine
[4]. It has been reported in mouse models that PGE2 stimulates
intestinal epithelial growth [4,5]. Recent studies in mouse models
of DSS colitis suggest that preservation of epithelial proliferation
depends on PGE2 production [6,7]. PGE2 is also found to exert
growth-stimulatory effects on intestinal tumors, and exogenous
administration of PGE2 provides a growth advantage to intestinal
neoplasms [8,9]. On the other hand, disruption of the COX-2 or
the E-prostanoid receptor 2 (EP2) gene result in a substantial
reduction of polyps in APC knockout mice [10,11].
The absorptive epithelium of the small intestine is organized in
crypts and villi, and is the most rapidly self-renewing tissue in adult
mammals. Villous epithelium contains three types of mature
epithelial cells; the enterocytes, the goblet cells and the
enteroendocrine cells. The crypts are mainly occupied by
undifferentiated rapidly proliferating cells in addition to Paneth
cells and a functional stem cell compartment [12,13].
PGE2 has been reported to be important for the regulation of
growth and differentiation in haematopoietic and mesenchymal
stem cells [14,15]. Furthermore, recent data suggest PGE2 to be
part of a master switch for growth regulation in somatic stem cells,
in general [16]. Wnt signalling which has been established as the
major signalling pathway driving proliferation in the intestinal
epithelium [17], is affected by PGE2 trough a PKA dependent
pathway leading to GSK3b inhibition and b-catenin stabilization
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elicit elevation of cAMP and PKA activation in the cell [18]. By
this mechanism PGE2 is able to contribute to Wnt driven
proliferation. Effect of PGE2 on proliferation depends on EP
receptor expression and the presence of PGE2 producing cells.
Detailed transcriptional studies of pure human epithelial cells
have been hampered by the inability to properly dissect the tissue.
Most molecular insight concerning EP receptor and COX
expression has been performed in whole mucosal tissue, which
includes a variety of cells. Some successful experiments combining
laser microdissection with immunohistochemistry on thin sections
have been reported, but RNA qualities have been poor [19]. In
this study we combined fresh flash-frozen tissue and cryosectioning
at 220u with a novel, gentle post-fixation and staining protocol
before laser microdissection. A slightly modified commercial RNA
isolation method resulted in RNA of acceptable quality for cDNA
synthesis and RT-PCR from as few as 200 cells.
The suggested role of PGE2 in regulation of growth and
differentiation of adult stem cells and the reports of PGE2 as a
stimulator of intestinal epithelial growth, led us to investigate the
possibility of PGE2 affecting human intestinal stem cells. In this
work we have identified COX1/2 and EP-receptor expressing cells
and investigated how these are localized relative to Lgr5 positive
putative stem cells in human small intestine and colon tissue.
Epithelial EP receptor and COX expression patterns were
identified in normal and inflamed human small intestine and
normal large intestine.
Methods
Immunohistochemistry
Tissue was immersed in 4% formalin for 2–3 hours within 10–
20 minutes after removal from the patient. Then the tissue was
dehydrated in a graded ethanol series and infiltrated in paraffin.
Tissue sections (7 mm) were obtained with a Leica RM2245 rotary
microtome (Leica Microsystems, Germany) and mounted on
coated glass slides. Sections were then de-waxed in Histolene
clearing agent for 365 minutes at room temperature (RT). Tissue
sections were rehydrated through a graded ethanol series before
antigen retrieval. Antigen retrieval were performed for 20 minutes
in boiling 1M sodium citrate buffer pH 6.0, followed by cooling to
RT for 20 minutes. For the anti-EP and CD45 immunohisto-
chemistry experiments antigen retrieval was performed using
IHC-Tek Epitope Retrieval Solution (IHC World, Woodstock,
MD) and an IHC-Tek Epitope Retrieval Steamer set (IHC World,
Woodstock, MD). Slides were incubated in the steamer for 40
minutes followed by 20 minutes at RT. Remaining buffer was
gently wiped off before the tissue specimens were encircled with a
PAP pen and placed in a humid chamber. The tissue sections were
incubated for 1 hour at RT with blocking solution, 5–7% of
secondary antibody host serum in TBS-T buffer, before primary
antibody solution was added. Incubation with primary antibody
was performed overnight at 4uC. Primary antibody solution was
removed and sections were washed briefly in TBS-T buffer before
secondary antibody solution was added. Sections were incubated
with secondary antibody for 1 hour at RT in the dark. Sections
were again washed in TBS-T buffer, before the nuclear stain
Hoechst 3342 was added for 10 minutes at RT (Sigma-Aldrich, St
Louis, MO). Slides were mounted either with immersion oil or
ProLong Gold antifade reagent (Invitrogen, UK).
The following primary and secondary antibodies were used in
this study;
Rabbit polyclonal anti- GPR49/LGR5 (#LS-A1232 and #LS-
A1236, MBL, Woburne, MA), goat polycolonal anti-COX-1 and
goat polyclonal anti-Cox-2 (M19)[20] (Santa Cruz Biotechnology,
Santa Cruz, CA), mouse monoclonal CD133 (clone AC133)
(Miltenyi Biotech, Germany)[21], donkey anti-rabbit IgG FITC,
rabbit anti-goat IgG Texas Red, goat anti-mouse IgG Cy3, goat
anti-rabbit IgG FITC (Jackson ImmunoResearch, UK). Rabbit
polyclonal anti-human Prostaglandin E2 receptor EP1 subtype,
rabbit polyclonal anti-human Prostaglandin E2 receptor EP2
subtype, rabbit polyclonal anti-human Prostaglandin E2 receptor
EP3 subtype, rabbit polyclonal anti-human Prostaglandin E2
receptor EP4 subtype (Genway, CA), monoclonal mouse CD45
(clone 2B11) (DAKO, Denmark)[22,23], mouse KI67 antigen
(clone MM1)[24] (Monosan, Netherlands), goat anti-mouse IgG-
FITC (Southern Biotech, Birmingham, AL). All slides were
examined with a Leica SP5 confocal laser microscope (Leica
Microsystems, Germany). Antibody blocking peptides used in the
study were; PTGER1 petide (GWB-TK4210) PTGER2 peptide
(GWB-4S87FM), PTGER3 peptide (GWB-J273CX), GWB-
38WU1H (Genway, San Diego, CA) and Cox2 (M19)P (Santa
Cruz Biotechnology, Santa Cruz, CA).
Tissue/Biopsies
The collection of tissue samples have been approved by
Regional Committees for Medical and Health Research Ethics
(REK). All patients have given their written consent on consent
form approved by the committee. Normal ileal tissue was obtained
from the terminal ileum of patients undergoing right hemicolec-
tomy resections for colon cancer, and normal colon was obtained
from sigmoidal resections in patients with rectopexia. Inflamed
small intestinal tissue was dissected from patients with untreated
coeliac disease.
Laser microdissection (LMD)
Tissues from human colon and small intestine were collected
during scheduled operations at the clinic, oriented, and flash-
frozen in liquid nitrogen. Tissue samples were mounted in Tissue-
Tek mounting media (Sakura, Torrance, CA) in a cryostat at
220uC. 8 mm sections were obtained at 220uC, and collected on
PEN (polyethylene naphthalate) membrane slides for microdissec-
tion (Leica Microsystems, Germany). Sections were briefly dried at
RT, before post-fixed in ice-cold acetone for 2 minutes and
washed in ice-cold diethylene pyrocarbonate (DEPC) treated
dH2O. Sections were stained with Toluidine Blue in DEPC-
treated dH2O for 1 minute and washed. Sections were left to dry
at RT for approximately 5 minutes. Excess liquid was gently wiped
off.
Laser micro dissection were performed on a Leica LMD 7000
(Leica Microsystems, Germany), and all removable parts were
wiped off with RNAseHZap solution prior to dissection (Ambion
Applied Biosystems, Austin, TX). RNAse free 0.5 ml vials were
mounted in the collection device.
Normal intestinal tissue crypts were divided into two popula-
tions based on localization, the crypt high population was dissected
from position +6 and upwards while the crypt low population was
dissected from position +5 and downwards and include the crypt
base (Figure 1A). Ten different templates were utilized in these
experiments; normal small intestinal crypt high, normal small
intestinal crypt low, normal small intestine below +4, inflamed
small intestine crypt cells, inflamed total tissue, small intestine total
tissue, normal colon crypt high, normal colon crypt low and
normal colon total tissue. Total tissue in this experiment means a
mixture of crypt epithelial cells and lamina propria cells. Cells
belonging to the different populations were dissected out according
to manufacturer’s recommendations and collected in tubes
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ice for approximately 1 hour.
RNA extraction and cDNA synthesis
Microdissected cells were collected in 65 ml RLT lysis buffer
with mercaptoethanol according to manufacturer’s recommen-
dations. RNA was extracted according to the manual for Qiagen
RNeasy Micro Kit (Qiagen, Germany), LMD tissue. RNA was
eluted in 14 ml RNAse-free water. cDNA synthesis was
performed by using SuperScriptH VILO
TM cDNA Synthesis
Kit (Invitrogen, UK) according to the manufacturer’s recom-
mendations. cDNA synthesis program: 25uC 10 minutes, 42uC
90 minutes, 85uC5m i n u t e s ,4 uC forever (MJ Thermocycler,
Watertown, MA).
RT-PCR
PCR was performed using SYBR GreenER qPCR reaction
system (Invitrogen, UK) according to the manufacturer’s recom-
mendation. Template cDNA was always measured on a Nanodrop
to be 300 ng (Thermo Scientific, Waltham, MA). All PCR reactions
were analyzed using a Rotor Gene 6000 Real-Time PCR Machine
(Corbett Life Science). The following PCR program was used:
50uC 2 minutes, 95uC 5 minutes, 95uC 15 seconds, 60uC1
minute (40 cycles of two last steps). Melting curve analyses were
performed for all real-time PCR runs to verify amplification of
only one product and to exclude false positive results.
The following primers were used in this study:
EP1: Qiagen QuantiTect Primer Assay, Hs_PTGER1_1_SG
EP2_forward: GTGCTGACAAGGCACTTCAT
EP2_reverse: GTCACTGTTTGGGGTTTCAA
EP3_forward: GGATCATGTGTGTGCTGTCC
EP3_reverse: AACTGGAGACAGCGTTTGC
EP4_forward: GACCTGTTGGGCACTTTGTT
EP4_reverse: TGGACGCATAGACTGCAAAG
Lgr5_forward: CTCTTCCTCAAACCGTCTGC
Lgr5_reverse: GATCGGAGGCTAAGCAACTG
Cox1_forward: GAGTACTGGAAGCCGAGCAC
Cox1_reverse: GCACTCTGGAATGACAAGCA
Cox2_forward: CTAGAGCCCTTCCTCCTGTG
Cox2_reverse: AAAACTGATGCGTGAAGTGC
DEFA5_forward: GCCATCCTTGCTGCCATT
DEFA5_reverse: GCTTCTGGGTTGTAGCCTCATC
GAPDH_forward: GAGTCAACGGATTTGGTCGT
GAPDH_reverse: TTGATTTTGGAGGGATCTCG
Figure 1. Identification of putative stem cells.P a r a f f i ns e c t i o n so fn o r m a lh u m a ns m a l li n t e s t i n a lt i s s u ew e r ep r e p a r e df o r
immunohistochemical analysis with a) anti-CD133 antibody identifies several positive cells from +4 position and upwards (indicated by arrows),
b) anti-Lgr5 antibody identify positive cells in +4 positions (indicated by arrows). The nuclei were stained with Hoechst 33342, c) In situ hybridization
of normal human small intestine for Olfm4 reveals an expression pattern similar to the expression of Lgr5, in the +4 position, d) Sections of normal
human small intestinal tissue were prepared for immunohistochemical analysis with anti-Ki67 antibody to identify proliferating cells. Positive cells are
indicated with arrows (pa = Paneth cells), e) Paraffin sections of normal human colon tissue were prepared for immunohistochemical analysis with
anti-Lgr5 antibody, and positive cells are identified in the crypt base (indicated by arrows), f) In situ hybridization of normal human colon for Olfm4
reveals an expression pattern similar to the expression of Lgr5 at the crypt base. g) Sections of normal human colon tissue were prepared for
immunohistochemical analysis with anti-Ki67 antibody to identify proliferating cells.
doi:10.1371/journal.pone.0026816.g001
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RPII_reverse: GTGCGGCTGCTTCCATAA
In situ hybridization
cRNA probes were generated from Olfm4 cDNA from
normal human small intestine using RNA labelling kit (SP6/
T7) according to the manufacturer’s protocol (Roche Applied
Science, Indianapolis, IN). 12 mm cryo sections from normal
human small intestine or colon were post fixed with 4%
paraformaldehyde for 20 min at RT. The sections were then
treated with 0.1% active DEPC in PBS for 2615 min before
15 min equilibration in 56SCC pH 7.5. Prehybridization was
continued for 2 h at 63uC before a 24 h hybridization step with
500 ng/ml probe at 63uC. The sections were then washed
30 min at room temperature with 26SCC, 1 h with 26SCC at
65uC and 1 h with 0.16SCC at 65uC. Equilibration in Tris/
NaCl buffer with 0.1% Tween 20 was done before 2 h
incubation with anti-DIG antibody (1:2000) (Roche Applied
Science) in blocking buffer (Roche Applied Science). Washing
was done in Tris/NaCl buffer for 2615 min before 5 min
equilibration in NTM buffer. Incubation with substrate was
done over night in the dark. The slides were then mounted and
investigated by light microscopy.
Figure 2. Lgr5 gene expression in normal human intestine. a) Schematic illustration of how the crypts of human intestinal tissue were divided
into different populations,b )Cells from the different populations described above were dissected by LMD from normal human small intestine and
colon, and inflamed small intestinal tissue. RNA were isolated from the dissected cells and analyzed by RT-PCR for the expression of Lgr5.
Amplification of Lgr5 PCR producs were verified by correct melting temperature.
doi:10.1371/journal.pone.0026816.g002
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Identification of putative stem cells in the crypts of
human small and large intestine
For PGE2 to affect epithelial cell proliferation the receptors
must be expressed together with intestinal stem cells or transit
amplifying (TA) cells. The exact location of the intestinal stem cells
(ISCs) has remained controversial. This has primarily been due to
the lack of unique molecular markers. The glycoprotein CD133 is
expressed in immature hematopoietic stem cells, as well as other
stem and progenitor cells including neural and embryonic stem
cells [25,26]. Monoclonal antibodies against CD133 have also
been used to identify colon cancer stem cells [27,28]. The
expression of CD133 in normal human intestine was investigated
by immunohistochemistry. In normal small intestine, we found
CD133 positive cells among the epithelial crypt cells, as well as in
cells adjacent to the crypts. The CD133 positive cells detected in
the crypts were found in the lower parts of the crypts, i.e. in the
vicinity of the suggested intestinal stem cell positions (Fig. 1a). No
CD133 positive cells were detected in normal colon crypts (data
not shown). Controls with secondary antibody, only, were
consistently negative (Figure S1a–b).
The orphan G-protein coupled receptor Lgr5/GPR49 has
recently been shown to specifically label stem cells in the mouse
small intestine as well as other adult tissues [29]. In this study,
antibodies against Lgr5/GPR49 were used to localize the
predicted intestinal stem cells of the human small and large
intestine. By using a combination of two antibodies raised against
Lgr5/GPR49, one against the N-terminal extracellular domain
(LS-A1232) and one against the C-terminal domain (LS-A1236),
we obtained a satisfactory bright and precise positive signal. In
crypts of the small intestine we detected Lgr5 positive cells at
approximately position +4, directly above the Paneth cells at the
crypts base (Fig. 1b). The anti-Lgr5 antibodies failed to detect Lgr5
expression in crypt base columnar (CBC) cells that are localized
between the Paneth cells in murine models [29]. We also
investigated Lgr5 expression by RT-PCR. The finding of Lgr5
positive putative stem cells in position +4 by immunohistocheme-
istry led to division of the crypts into two populations; crypts high
above +5 and crypts low below +5 (Fig. 2a). Lgr5 transcripts were
found in the crypt low population which includes cells in the +4
position. Investigation of the cells below the +4 position that
included CBC cells and Paneth cells, only, revealed no detectable
Lgr5 mRNA expression (Fig. 2b). As expected, no Lgr5 transcripts
were detected in the crypt high population by PCR.
In human normal colon crypts we detected Lgr5 positive cells at the
crypt base, varying from 3–6 positive cells per crypt (Fig. 1c). PCR
confirmed Lgr5 expression only in crypt low population of normal colon
Figure 3. EP-receptor gene expression in normal and inflamed human intestine. Cells from the different populations described above were
dissected by LMD from normal human small intestine and colon, and inflamed small intestinal tissue. RNA were isolated from the dissected cells and
analyzed by RT-PCR for the expression of EP-receptors 1-4. Amplification of the EP receptor PCR products were verified by correct melting
temperature.
doi:10.1371/journal.pone.0026816.g003
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antibody, only, were consistently negative (Figure S1 e,f,h,i).
Immunhistochemistry on U937 cells shown not to express any
transcript for Lgr5 confirmed the specificity of the antibody (Figure S2).
Olfactomedin-4 (Olfm4) is reported to be a robust marker of
Lgr5+ cells [30]. We performed in situ hybridization experiments
on cryo sections of normal human small intestine and colon (Fig. 1c
and f). Olfm4 is expressed in the +4 position in normal human
small intestine and at the crypt base of normal colon tissue. This is
the same expression pattern found for Lgr5 using immunohisto-
chemistry. Controls with sense probes were consistently negative
(Figure S1 j–k).
Identification of proliferating cells in intestinal crypts.
Both the transit amplifying cells and the intestinal stem cells are
proliferating cells and should be positive for the proliferation
marker Ki67 by immunhistochemistry. In normal small intestine
Ki67 positive cells were identified from position +4 and upwards to
the top of the crypt (Fig. 1d and g). In normal colon Ki67 positive
cells were identified all the way from the crypt base to the crypt
top. This is in accordance with the Lgr5 and Olfm4 data and
confirms that no proliferating cells are found below position +4i n
the epithelium of normal small intestine.
Profiling of EP receptor expression by RT-PCR on
microdissected crypt cell populations
Prostaglandins, particularly PGE2, have been shown to be
important for stem cell proliferation in vertebrates [14] and to play
a role in the regulation of epithelial cell growth in response to
injury [6,7]. PGE2 binds to and mediate signaling through four
different receptors, EP1-4. We therefore investigated the EP-
receptor mRNA expression profile by RT-PCR. Laser microscopy
dissection (LMD) combined with cryosectioning, RNA isolation
and cDNA synthesis was followed by RT-PCR. In normal small
intestinal crypts we failed to detect transcripts for any of the EP
receptors in both the crypt high and crypt low populations (Fig. 3).
When total small intestinal tissue was used as a template, however,
all transcripts were expressed. We also investigated inflamed small
intestinal tissue from patients with untreated celiac disease (Fig. 3).
In epithelial crypt cells from this tissue we were able to detect
expression of transcripts for EP-receptors 2 and 4. EP1 and EP3
transcripts were not detected. In the total tissue template from
inflamed tissue all transcripts examined were detected.
In epithelial cells from normal colon tissue we detected
transcripts of EP2 and EP4 receptors in both crypt high and crypt
low populations. Transcripts of the two reference genes GAPDH
and RPII were present in all templates (Fig. 3).
Identification of EP1–4 and CD45 positive cells in human
intestinal tissue
In these experiments we made use of recently developed rabbit
polyclonal antibodies raised against peptides from the extracellular
domains of the four different EP receptors. We tested these
antibodies by immuncytochemistry on a human mesenchymal
stem cell line (hTERT) as a positive control (data not shown). We
detected EP1- and EP3-positive cells in the lamina propria of both
normal colon and small intestine (Fig. 4 a, b, e, f), but no signal was
observed in epithelial crypt cells in either tissues. EP2- and EP4-
expressing cells were found both in the lamina propria and among
epithelial crypt cells of colon (Fig. 4 c, g), but in small intestinal
tissue EP2- and EP4-expression was restricted to cells in the
lamina propria (Fig. 4 d, h). Controls with normal rabbit IgG, with
secondary antibody and peptide inhibition were all consistently
negative (Figure S1 d,e, f,g,h,i and S3a–d).
The expression of EP-receptors was also investigated in
inflamed small intestinal tissue obtained as biopsies from patients
Figure 4. Identification of EP receptors in normal human intestine by immunhistochemistry. a–b) Anti-EP1 antibody detects positive
cells in the lamina propria in both colon (a) and small intestinal tissue. No expression is found in crypts. (b), c–d) Anti-EP2 antibody detects positive
cells in colon crypts (c), but not in small intestine crypts where EP2 expression is detected in lamina propria only (d), e–f) Anti-EP3 antibody detects
positive cells in the lamina propria in both colon (e) and small intestinal tissue (f). No expression is found in crypts, g–h) Anti-EP4 antibody detects
positive cells in colon crypts (g), but not in small intestine crypts where EP4 expression is detected in lamina propria only. Nuclei are stained with
Hoechst 33342.
doi:10.1371/journal.pone.0026816.g004
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staining pattern of the lamina propria was similar to what was
found in normal tissue (Fig. 5 d, e, h, i). However, EP2- and EP4-
expression, were clearly detected in epithelial crypt cells of small
intestine (Fig. 5 f, g, j,k). To rule out the possibility that the EP2-
and EP4-positive crypt cells were intraepithelial lymphocytes we
also stained the same tissue with monoclonal anti-CD45
antibodies. Numerous CD45-positive cells were observed in the
inflamed lamina propria, but no CD45 positive cells were found in
the crypt epithelium (Fig. 5 a–c). Normal mouse and rabbit IgG,
secondary antibody and peptid inhibition experiments were
performed to ensure antibody specificity (Figure S1 a–b).
Identification of COX-1 and COX-2 positive cells in
human intestinal tissue.
PGE2 is produced by the enzymes COX-1/2. COX-1 is regarded
as constitutively expressed while COX-2 is induced by different
stimuli.WethereforeinvestigatedtheCOX-1andCOX-2expression
and localization in human intestinal tissue. Cellular expression of the
COX-1 and COX-2 was investigated by immunohistochemistry in
Figure 5. Identification of EP receptors and CD45 in inflamed human small intestine by immunhistochemistry. a–c) CD45 antibody
detected positive CD45 cells in the lamina propria (lm) in inflamed tissue. No positive CD45 cells were detected in crypts (cr), d–e) Anti-EP1 antibody
detected positive cells in the lamina propria, but no EP1 expression were detected in crypt cells, f–g) Anti-EP2 antibody detected positive cells in
both lamina propria (f) and crypts (g), h–i) Anti-EP3 antibody detected positive cells in lamina propria only; no positive cells were detected in crypts,
j–k) Anti-EP4 antibody detected positive cells in both lamina propria (j) and crypts (k). Nuclei are stained with Hoechst 33342.
doi:10.1371/journal.pone.0026816.g005
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COX-1 positive cells in the epithelium of normal and inflamed small
intestine. A high number of COX-1 positive cells were found in the
lamina propria of normal tissue, and the expression was increased in
inflamed tissue of untreated celiac disease patients (Fig. 6a and b).
COX-1 expression was, however, detected both in epithelial crypt
cells and the lamina propria of normal colon (Fig. 6c). These
immunohistochemistry data corresponds with mRNA expression
data (Fig. 6d).
In the small intestine a modest number of COX-2 positive cells
were detected in or in close proximity to the epithelial cells in the
crypts (Fig. 7a). PCR confirmed that these COX2 positive cells
were not localized to the epithelium but were lamina propria cells
(Fig. 7d). Numerous COX-2 positive cells were detected in the
lamina propria of inflamed small intestine (Fig. 7b). As opposed to
the situation in the small intestine, COX-2 positive epithelial crypt
cells were identified in normal colon (Fig. 7c). Investigation of
mRNA expression with qPCR confirmed COX-2 expression in
epithelial cells of colon crypts. These cells were randomly scattered
among the epithelial crypt cells. No positive cells were detected in
the lamina propria of normal colon (Fig. 7d). Peptide blocking
experiments were performed to confirm the immunohistochemis-
try data (Figure S3e-f).
Discussion
Recent studies in mice suggest that PGE2 is important to
maintain mucosal integrity [4,5,6,7,31]. Inhibition of COX
expression in the intestinal mucosa has been found to reduce the
levels of PGE2 and inhibit proliferation of intestinal epithelial cells
[4]. If PGE2 has a direct effect on intestinal epithelial proliferation
this is most likely due to effects on intestinal stem cells and/or
transit amplifying cells. The biological effects of PGE2 are
mediated through binding to the corresponding EP receptors 1–
4. We investigated both the transcript levels of the EP receptors by
RT-PCR as well as characterized the distribution and localization
of the receptors by immunohistochemistry. Immunhistochemistry
and RT-PCR results both conclude that EP2 and EP4 receptors
were expressed in colon epithelial crypt cells, whereas EP1 and
EP3 receptors were absent. In colon, EP receptors of all the 4
subtypes were expressed on cells of the lamina propria while only
EP2- and EP4-expression was detected among the epithelial crypt
cells. It is previously reported by Takafuji and co-workers that EP3
receptors is expressed at the apex of normal colonic crypts [32].
However, we are not able to detect EP3 receptor expression in
colonic crypts, neither on gene nor protein level.
In normal small intestinal epithelium none of the EP receptors
were present, neither at the top nor at the bottom of the crypts. In
total mucosal tissue all transcripts were found and all receptors
were detected by antibodies. The inflamed epithelium from
untreated patients with celiac disease, expressed EP2 and EP4 in
crypt cells, but still no EP1 and EP3 expression were observed.
However, all receptors were expressed in total mucosal tissue. The
transcript distribution found by RT-PCR was fully confirmed by
the immunohistochemistry experiments.
Figure 6. Identification of COX1 in normal and inflamed human intestine. Paraffin sections were prepared for immunohistochemical
analysis with anti-COX1 antibodies and the nuclei were stained with Hoechst 33342, a) Normal human small intestine showing positive COX1 cells in
lamina propria, b) Human small intestine from patients with untreated celiac disease showing positive COX1 cells in lamina propria, c) Normal human
colon showing positive COX1 cells in lamina propria, d) Cells from the different populations described above were dissected by LMD from normal
human small intestine and colon, and inflamed small intestinal tissue. RNA were isolated from the dissected cells and analyzed by RT-PCR for the
expression of COX1. Amplifications of the COX1 PCR products were verified by the correct melting temperature.
doi:10.1371/journal.pone.0026816.g006
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lymphocytes (IEL) and the number of these is expected to increase
during inflammation [33]. The detection of EP2 and EP4
receptors in inflamed small intestinal crypts could therefore be
due to increased expression of these receptors on IEL. However,
staining with antibodies against CD45 did not reveal any positive
cells among the epithelial crypt cells. The EP2 and EP4 receptors
found in inflamed small intestinal epithelium are therefore
assumed to be expressed on epithelial crypt cells.
The EP receptors differ in their affinity for PGE2 and
downstream signaling. PGE2 is reported to affect proliferation
by interacting with the Wnt signaling pathway trough a PKA
dependent inhibition of GSK3b[15,16]. PGE2 induces elevation
of cAMP and subsequent PKA activation by binding to EP2 and/
or EP4 receptors. Our findings of EP2 and 4 receptor transcripts
in epithelial cells of normal colon tissue and inflamed small
intestine make it plausible that PGE2 interacts directly with these
cells and modulate their proliferation.
Studies of haematopoietic stem cells show that PGE2 is involved
in regulation of the stem cell niche and of the stem cell itself [14].
Also, in human mesenchymal stem cells PGE2 is involved in
regulating stem cell proliferation [15]. Until now the exact location
of intestinal stem cells has been a controversial issue. This has
primarily been due to the lack of unique molecular markers.
Recent studies in mouse models have identified a single marker,
Lgr5/GPR49, a leucine-rich orphan G-protein-coupled receptor,
that specifically labels stem cells in the mouse small intestine as
well as other adult tissues [25,26,29]. Furthermore, CD133
(Prominin 1) has been used as a colon cancer stem cell marker
[34], and it has also been suggested as a reliable marker for
intestinal stem cells [35]. In the present study a combination of two
different anti-Lgr5 antibodies revealed positive cells in both small
intestinal and colon crypts. The localization of these cells is in
accordance with previously reported findings of intestinal crypt
stem cells in humans [36]. We did not observe co-localization of
CD133 positive and Lgr5 positive cells in crypts of the small
intestine, and CD133 positive cells were not detected at all in
colonic crypts. Studies of Prom1/CD133 knock-in mice have
demonstrated Prominin 1 mRNA expression in the lower parts of
the crypts, but not overlapping with the Lgr5 transcript expression
[37] Our conclusion is that CD133 may be expressed by some
putative stem cells, but is not a specific stem cell marker as it also
seems to stain early transit amplifying cells and cells in lamina
propria. This is in accordance with data from Snippert and
collaborators [38].
By immunohistochemistry we identified Lgr5 positive cells in
position +4 in human small intestine. We were not able to detect
Lgr5 protein expression among the slender cells intercalating
between the Paneth cells, also known as the crypt base columnar
(CBC) cells, reported by others [29,39]. This could be explained
Figure 7. Identification of COX2 in normal and inflamed human intestine. Paraffin sections were prepared for immunohistochemical
analysis with anti-COX2 antibody (crypts are indicated with dashed lines). a) Normal human small intestine. Positive COX2 cells in the lamina propria
are indicated by arrows, b) Human small intestine from patients with untreated celiac disease show positive COX2 cells in lamina propria, c) Normal
human colon. Positive COX2 cells in epithelial crypts are indicated by arrows, d) Cells from the different populations described above were dissected
by LMD from normal human small intestine and colon, and inflamed small intestinal tissue. RNA were isolated from the dissected cells and analyzed
by RT-PCR for the expression of COX2. Amplifications of the COX2 PCR products were verified by correct melting temperature.
doi:10.1371/journal.pone.0026816.g007
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but it could also be due to lack of Lgr5 expression in human CBC
cells. Investigation of RNA isolated from cells below the +4
position, including Paneth cells and CBC cells, using LMD and
RT-PCR, did not reveal any Lgr5 transcripts. The CBC cells were
identified by transmission electron microscopy (data not shown).
These two different approaches both suggest that Lgr5 positive
cells are only found at position +4 in normal human small
intestine. The murine Lgr5-positive CBC cells are reported to be
proliferating cells positive for the Ki67 marker [29]. We were not
able to detect any Ki67 cells below the +4 position in human small
intestine (data not shown). In human colon up to six Lgr5-positive
cells were identified at the crypt base. These were either
neighbouring cells or separated by 1–2 unidentified cells. Cells
intermingling with Lgr5-positive cells in colon are previously
suggested to be goblet cells [40]. We primarily observed goblet
cells near the top of the crypts, and their frequency decreased
gradually towards the crypt base where no positive staining for
goblet cells was detected. These cells might be goblet-like or
Paneth-like cells, but they do not stain with Dolichos biflorus
agglutinin (DBA) or express human defensin alpha 5 (DEFA5)
mRNA (data not shown). Evidently, there are differences in how
the Lgr5-positive cells are organized in human colon versus small
intestine both with regard to the type of cells they are surrounded
by, and by number and localization.
In the mouse, crypt stem cell survival has previously been
reported to depend on prostaglandins synthesized through COX-1
[41]. Cohn et al. found COX-1 to be constitutively expressed in
epithelial cells of normal mouse intestine, and additionally up-
regulated in response to injury. However, COX-2 expression has
not been reported among the crypt epithelial cells of normal
intestine, but is reported to be up-regulated in adenomas and
carcinomas as well as in inflammatory bowel disease [42,43,44]. In
normal human small intestinal tissue we detected a modest
number of COX-2 positive cells in the lamina propria close to the
crypts. These COX-2 positive cells could be subepithelial
myofibroblast-like cells which are expected to be important for
regulation of intestinal stem cells [45]. No COX-1 positive cells
were identified in normal human small intestine. In normal colon
tissue the situation was different. Here, COX-2 positive cells were
randomly distributed among the epithelial cells within the crypts,
while no positive cells were detected in the surrounding tissue.
COX-1 positive cells were found in the lamina propria of normal
colon, and also a few crypt cells expressed COX-1. Interestingly,
there were more COX-1 and 2 positive cells in the lamina propria
of inflamed small intestinal tissue from untreated celiac disease
patients. This increase in COX-positive cells could be due to up-
regulation of the protein in lamina propria cells or recruitment of
COX-positive cells due to the inflammation as reported by [7].
The present study reveals several distinct differences EP
receptor-expression of cells in human intestinal epithelium. EP2/
4 receptors are all expressed in the epithelium of normal colon
crypts, but not in normal small intestinal crypts. These results
indicate that PGE2, produced by cells of the intestinal crypt
epithelium, may have a direct growth-promoting effect on stem
cells and transit amplifying cell of normal human colon. On the
other hand, we do not find any evidence for such direct effects on
epithelial crypt cells of normal human small intestine. However,
we find the levels of these molecules to be up-regulated in inflamed
tissue from patients with untreated celiac disease. Thus, inflam-
mation induces expression of these molecules and could represent
a mechanism for regulation of growth during inflammatory
conditions. Furthermore, there could be indirect growth-regula-
tory effects of PGE2 via lamina propria cells producing cytokines
affecting epithelial crypt cell proliferation and maturation.
We also identified differences in the localization of Lgr5-positive
putative stem cells in human colon versus small intestine.
Moreover, our data are not in agreement with recent reports
from mouse experimental models suggesting that Lgr5-positive
stem cells are found at the crypt bottoms of the small intestine.
Supporting Information
Figure S1 Control experiments for immunhistochemis-
try and in situ hybridization experiments. Paraffin sections
were prepared for immunohistochemical analysis with a. Rabbit
anti-mouse IgG Cy3 secondary antibody only, b. inflamed small
intestine incubated with normal mouse IgG instead of primary
antibody, c. inflamed small intestine incubated with goat anti-
mouse-FITC secondary antibody only, d. inflamed small intestine
incubated with normal rabbit IgG instead of primary antibody, e.
normal small intestine incubated with normal rabbit IgG instead of
primary antibody, f. normal colon incubated with normal rabbit
IgG instead of primary antibody, g. inflamed small intestine
incubated with goat anti-rabbit-FITC secondary antibody only, h.
normal colon incubated with goat anti-rabbit-FITC secondary
antibody only, i. Normal small intestine incubated with goat anti-
rabbit-FITC secondary antibody only. All nuclei were stained with
Hoechst 33342 j. in situ hybridization for Olfm4 normal small
intestine, sense control probe, k. In situ hybridization for Olfm4
normal colon, sense control probe
(TIF)
Figure S2 Verification of the specificity of Lgr5 anti-
body. Cells were prepared for immunhistochemical analysis with
Lgr5 antbody. a. Rabbit anti-Lgr5 and goat anti-rabbit-FITC
identifies expression of Lgr5 on Caco2 cells. b. Rabbit anti-Lgr5
and goat anti-rabbit-FITC identifies expression of Lgr5 on
mesenchymal stem cells represented by the hTERT-20 cell line.
c. No Lgr5 expression could be detected on the U937 cells. Nuclei
are stained with Hoechst 3342. d. Fragments amplified by PCR
were run on an agarose gel; Lgr5 was not amplified from U937
(lane 1), but were detected in both Caco2 and hTERT-20 cells
(lane 2 and 3). There was no amplification in the no template
control (lane 4). The house keeping transcript RPLPO was
amplified in U937, Caco2 and hTERT-20 (lane 5, 6 and 7). NEB
100 bp ladder was used for fragment size determination.
(TIF)
Figure S3 Control experiments with blocing peptides.
Paraffin sections were prepared for immunohistochemical analysis
with a. Rabbit anti-EP1 incubated with EP1 peptide which resulted
in complete loss of positive EP1 cells in human colon. b. Rabbit anti-
EP2 incubated with EP2 peptide which resulted in complete loss of
positive EP2cellsin human colon.c.Rabbit anti-EP3 incubated with
EP3 peptide which resulted in complete loss of positive EP3 cells in
human colon. d. Rabbit anti-EP4 incubated with EP4 peptide which
resultedincompletelossofpositiveEP4cellsinhumancolon.e.Goat
anti-COX2 incubated with COX2 peptide resulted in complete loss
of positive COX2 cells in human normal colon. f. Goat anti-COX2
incubated with COX2 peptide resulted in complete loss of positive
COX2cellsinhumansmallintestine.Thecorrespondingpeptidewas
used with a 1000x molar excess in all experiments.
(TIF)
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